Found 2 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Potassium channel subfamily K member 9
(Homo sapiens (Human)) | BDBM458972
((4-{[2-(4-Bromophenyl)imidazo[1,2-a]pyridin-3-yl]m...)Show SMILES Fc1ccc(Cl)c(c1)C(=O)N1CCN(Cc2c(nc3ccccn23)-c2ccc(Br)cc2)CC1 Show InChI InChI=1S/C25H21BrClFN4O/c26-18-6-4-17(5-7-18)24-22(32-10-2-1-3-23(32)29-24)16-30-11-13-31(14-12-30)25(33)20-15-19(28)8-9-21(20)27/h1-10,15H,11-14,16H2 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT
US Patent
| Assay Description
The investigations on the inhibition of the recombinant TASK-1 and TASK-3 channels were carried out using stably transfected CHO cells. Here, the com... |
US Patent US10759794 (2020)
BindingDB Entry DOI: 10.7270/Q2KK9FW6 |
More data for this
Ligand-Target Pair | |
Potassium channel subfamily K member 3
(Homo sapiens (Human)) | BDBM458972
((4-{[2-(4-Bromophenyl)imidazo[1,2-a]pyridin-3-yl]m...)Show SMILES Fc1ccc(Cl)c(c1)C(=O)N1CCN(Cc2c(nc3ccccn23)-c2ccc(Br)cc2)CC1 Show InChI InChI=1S/C25H21BrClFN4O/c26-18-6-4-17(5-7-18)24-22(32-10-2-1-3-23(32)29-24)16-30-11-13-31(14-12-30)25(33)20-15-19(28)8-9-21(20)27/h1-10,15H,11-14,16H2 | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
BAYER PHARMA AKTIENGESELLSCHAFT
US Patent
| Assay Description
The investigations on the inhibition of the recombinant TASK-1 and TASK-3 channels were carried out using stably transfected CHO cells. Here, the com... |
US Patent US10759794 (2020)
BindingDB Entry DOI: 10.7270/Q2KK9FW6 |
More data for this
Ligand-Target Pair | |